Protocol 331-13-008: An Exploratory, Multicenter, Open-label, Flexible-dose Brexpiprazole (OPC-34712) Trial in Adults With Acute Schizophrenia
Latest Information Update: 08 Oct 2016
At a glance
- Drugs Brexpiprazole (Primary) ; Aripiprazole
- Indications Schizophrenia
- Focus Registrational; Therapeutic Use
- Sponsors Otsuka Pharmaceutical Development & Commercialization
- 09 Mar 2016 Results published in the International Clinical Psychopharmacology
- 06 Mar 2016 Primary endpoint has been met. (Change From Baseline to Week 6 in Positive and Negative Syndrome Scale (PANSS) Total Score), as per an article published in the International Clinical Psychopharmacology.
- 01 Sep 2015 Results presented at the 28th Annual Congress of the European College of Neuropsychopharmacology